Design Therapeutics's total assets for Q1 2026 were $230.44M, an increase of 1.87% from the previous quarter. DSGN total liabilities were $12.39M for the fiscal quarter, a -9.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.